Inscripta's Series C Round

Inscripta raised a round of funding on February 28, 2018.

Inscripta, formerly Muse Biotechnology, is advancing genome engineering and synthetic biology technology (ForgeCraft) which combines computer-aided forward design software package, a proprietary bench…

Articles about Inscripta's Series C Round: